Home/News/SCHD ETF: $100.8 Billion Fund Offers 3.2% Yield from 100 Di…

ETF · July 24, 2026

SCHD ETF: $100.8 Billion Fund Offers 3.2% Yield from 100 Dividend Stocks

The Schwab U.S. Dividend Equity ETF (SCHD) provides a 3.2% yield from 100 large-cap stocks with 10+ year dividend histories, supported by a 55% payout ratio. Top holdings include Coca-Cola, Chevron, Merck, and Lockheed Martin.

SCHD ETF: $100.8 Billion Fund Offers 3.2% Yield from 100 Dividend Stocks

Fund Overview and Yield Mechanics

The Schwab U.S. Dividend Equity ETF (SCHD) manages approximately $100.8 billion in assets and tracks the Dow Jones U.S. Dividend 100 Index. The fund selects companies with at least 10 years of consecutive dividend payments, strong cash-flow-to-debt ratios, and consistent dividend growth. SCHD currently offers a 3.2% dividend yield based on $1.05 in annual distributions per share, with a fund-level payout ratio of 55%. The yield is derived solely from cash dividends paid by the underlying 100 large-cap U.S. companies, with no options overlay, leverage, or return-of-capital strategies. Each top holding carries roughly a 4% weighting. The fund's expense ratio is 0.06%.

Key Holdings and Dividend Safety

Dividend history for top holdings shows long-term growth. Coca-Cola (KO) raised its quarterly dividend to $0.53 from $0.51, extending a 63-year streak of annual increases. FY2026 guidance projects roughly $12.2 billion in free cash flow against $8.8 billion in dividends paid in 2025, providing a substantial cushion. Coca-Cola's 28% net margin and 43% return on equity indicate the dividend is funded from operations.

Chevron (CVX) increased its quarterly dividend to $1.78, marking its 39th consecutive annual increase. While Q1 2026 free cash flow was negative due to timing, FY2025 delivered $16.6 billion in free cash flow, with dividends consuming well under half that amount. The 3.8% yield is supported by durable cash flow, though energy-sector cyclicality remains a factor.

Merck (MRK) raised its quarterly dividend to $0.85 from $0.81, with the payout covered by earnings. However, KEYTRUDA generates roughly half of pharma revenue and faces a patent cliff late in the decade. Merck has incurred $14.8 billion in combined acquisition charges for Cidara and Terns to diversify its pipeline. The dividend is currently safe, but growth beyond 2028 depends on pipeline success.

Lockheed Martin (LMT) increased its quarterly dividend to $3.45, supported by a record $194 billion backlog. FY2026 guidance calls for $6.5 to $6.8 billion in free cash flow. Program-execution charges on F-16 and classified work are recurring risks, but multi-year revenue visibility underpins dividend growth.

Total Return and Risk Considerations

SCHD trades at about $33, up 21% year to date and roughly 26% over the past year, with a 55% five-year gain. The 10-year Treasury near 4.6% and Fed funds at 3.75% both yield more than SCHD's 3.2% payout, but investors accept lower current yield for dividend growth and equity appreciation. The fund's 55% payout ratio provides ample coverage. Key risks are concentrated: Merck's post-KEYTRUDA pipeline, Chevron's oil-price sensitivity, and Lockheed's program-execution volatility.

What it means for income investors

SCHD offers a diversified portfolio of 100 dividend-paying large-caps with a history of consistent payouts. The fund's mechanical structure and low expense ratio make it a straightforward vehicle for capturing dividend income, though its yield is lower than current bond rates. The safety of distributions rests on the financial health of its holdings, which have multi-decade dividend growth records.

Reporting based on: Yahoo Finance. Figures verified against market data where available.

Related news